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Abstract
Purpose To examine the content of phosphorylated
myosin regulatory light chain (P-MLC20) and myosin
light-chain kinase (MLCK) in the common bile duct of
pediatric patients with pancreaticobiliary maljunction
(PBM) accompanied by bile duct dilatation (BDD), and
investigate their potential role in PBM accompanied by
BDD.
Methods Twenty-one specimens of the common bile duct
from pediatric patients with PBM accompanied by BDD
were collected. P-MLC20 was examined with immuno-
histochemistry. The expression of P-MLC20 and MLCK
was also examined with Western blot. Twenty-one speci-
mens of the common bile duct from pediatric patients
without PBM and BDD were used as controls.
Results The mean optical density (MOD), mean labeling
intensity (MLI) and minimum qualifying scores (MQS) of
P-MLC20 were 115.6856 ± 58.1634, 21.7125 % ± 9.6555
and 21.3531 ± 6.5255, respectively. In the control
group, MOD, MLI and MQS were 96.5581 ± 9.7859,
11.1813 % ± 3.6208 and 10.7819 ± 3.5323, respectively.
There was no significant difference in MOD between the two
groups (P [ 0.05), whereas there was a significant differ-
ence in MLI and MQS between the two groups (P \ 0.05).
The expression of P-MLC20 and MLCK, as determined with
Western blot, was also significantly higher in the PBM group
than in the control group (P \ 0.05).
Conclusion P-MLC20 is associated with increased con-
tractile force of the smooth muscle of the common bile
duct in pediatric patients with PBM accompanied by BDD.
The enhanced expression of P-MLC20 in the common bile
duct probably contributes to increased bile duct pressure in
PBM via the MLCK pathway.
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Introduction
Pancreaticobiliary maljunction (PBM) is a congenital
anomaly in which the junction of the pancreatic and bile
ducts is outside the duodenal wall. Since the common duct of
the pancreaticobiliary duct is too long, Oddi’s sphincter
could not control the biliary–pancreatic confluence, and
results in abnormal hydrodynamics in the biliary–pancreatic
confluence [1, 2]. The pancreatic juice could reflux into the
common bile duct due to high pressure within the pancreatic
duct and lower pressure in the common bile duct. The bile
activates a variety of enzymes, such as phospholipase A2 and
proteases, in the pancreatic juice, and, leads to the break-
down, destruction and abscission of the epithelial elastic
fiber of the common bile duct. Chronic stimulation of the
common bile duct results in inflammation, thickening and
fibrosis of the wall, epithelial hyperplasia, and even cancer of
the common bile duct. The fibrosis of the common bile duct
leads to poor bile flow, increased inner pressure in the
common bile duct and cholestasis [3]. If pancreatic juice
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refluxes into the common bile duct, the bile flow is hampered,
leading to spindle-shaped or cystic dilatation of the common
bile duct. The morphological changes of the common bile
duct alter the function and structure of the common bile duct
wall [4]. However, the molecular mechanisms involved in
smooth muscle contraction change of the common bile duct
are still unclear.
Smooth muscle plays an important role in the common
bile duct wall [5]. Smooth muscle contraction is induced by
the sliding of thick against thin filaments. The intertwining of
the two myosin heavy chains (MHC) forms the rod-shaped
body and globular head of thick filaments [6]. The globular
head possesses ATPase activity, and provides the energy for
muscle contraction by ATP hydrolysis after binding to actin
in the thin filaments. Myosin regulatory light chain (MLC20)
is the primary regulatory domain of myosin. MLC20 func-
tions by phosphorylating myosin light chain kinase (MLCK)
and dephosphorylating myosin light chain phosphatase
(MLCP) [7]. The main mechanism regulating smooth mus-
cle contraction is the phosphorylation of MLC20, and the
degree of phosphorylation of MLC20 determines the speed
and intensity of muscle contraction [8]. Even mild change in
the expression of P-MLC20 significantly influences smooth
muscle contraction [9].
In the PBM patients, poor bile flow induces cholestasis.
Increase of inner pressure of the common bile duct and the
dilation of the common bile duct are the pathogenic basis of
the common bile duct cysts. Watanabe et al. [10] reported
that, in patients with congenital choledochal cyst (CCC) or
PBM, a small number of the patients were found to show
malignant transformation in their bile ducts in long-term
follow-up, even if the CCC was removed. Todani et al. [11]
reported that the residual extrahepatic bile duct continued to
be at risk for malignant transformation after PBM surgery.
The malignant transformation of the bile duct is primarily
due to chronic bile duct inflammation induced by pancreatic
juice reflux and destruction of the bile duct wall. Wang et al.
[12] reported that cytokines in response to chronic inflam-
mation could induce intestinal epithelial barrier dysfunction
by increasing the phosphorylation of MLC. Most of PBM
cases have chronic inflammation in bile duct wall [13].
Besides, the change of P-MLC20 can significantly influence
smooth muscle contraction [9]. Thus, it is necessary to
understand the expression and significance of P-MLC20 in
pediatric patients with PBM accompanied by BDD.
Materials and methods
General information
This study was approved by the Ethics Committee of the
Children’s Hospital affiliated to Soochow University.
Written informed consent was obtained from legal guard-
ians of the subjects following a detailed description of the
purpose of the study. All experiments were carried out in
strict accordance with the institution guidelines regarding
the acquisition and experimental use of human tissues.
Twenty-one specimens (dilatated common bile duct) from
patients (10 males and 11 females) with PBM accompanied
by BDD confirmed by imaging, surgery and pathology in
the Children’s Hospital affiliated to Soochow University
during a 3-year period from 2008 to 2011 were included in
the current study. The age of patients ranged from
19 months to 10 years (median age:3 years). The diagnosis
of PBM was defined as following [13, 14]: MRCP or IOC
shows that the common duct ([5 mm) of the pancreati-
cobiliary duct converges outside the Oddi’s sphincter, with
a biliary amylase concentration of [1,000 U/L. Twenty-
one specimens of the common bile duct of newborn
patients and pediatric patients who died due to diseases
other than bile duct and pancreatic diseases (age range: 37
gestational weeks to 9 years, with a median gestational age
of 2.8 years) were used as controls in immunohistochem-
istry test. The expression of P-MLC20 and MLCK of the
common bile duct cystic wall of 12 patients with PBM
accompanied by BDD and 9 patients (5 newborn and 4
pediatric patients) without PBM and BDD in the control
group was also analyzed by Western blot.
Methods
Immunohistochemistry
The expression of P-MLC20 was detected by an SP
immunohistochemical method. Briefly, the tissue embed-
ded in paraffin was serially cut at 4-lm sections. Sections
were deparaffinized, hydrated to water and incubated with
3 % H2O2 for 30 min at room temperature to eliminate
endogenous peroxidase. After rinsing with distilled water
and immersion in PBS, antigen was retrieved using a
microwave oven in citrate buffer (pH 6.0). Ten percent
goat serum was used to block non-specific binding. The
sections were incubated with the primary antibody (anti-p-
MLC20 antibody, 1:200 dilution) overnight at 4 C and for
an additional 45 min at 37 C. The sections were incubated
with a biotinylated secondary antibody for 20 min at 37 C
and then horseradish peroxidase (HRP)-labeled streptavi-
din for 15 min before addition of 3,30-diaminobenzidine
(DAB). Stained slides were counterstained with hematox-
ylin and eosin (HE). The positive controls were supplied by
LifeSpan Biosciences. In the positive controls, the smooth
muscle of the common bile duct shows a spindle pattern,
and the cytoplasm was stained yellow or brown (considered
as positive). The primary antibody was omitted in the
negative controls.
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Analysis of immunohistochemistry images
Quantification of the immunohistochemical staining of
P-MLC20 was carried out by two investigators blinded to
the clinical conditions using a light microscope. Acquired
images were analyzed by the IPP 6.0 image analysis soft-
ware. For each slide, five random fields (4009 magnifi-
cation) were selected. Image analysis was carried out
according to the methods described by Mady HH [15], and
included the following: (1) labeling index (LI), i.e., the
ratio of the positively stained area to the total area in
interested regions. (2) Mean optical density (MOD), i.e.,
the ratio of the integral optical density to the total area of
interested area. (3) A quick score (QS), calculated as the
numeric product of the LI with MOD.
Western blot
For 100-mg tissue, 1 m of RIPA buffer and 10 ul of PMSF
(phenylmethanesulfonylfluoride or phenylmethylsulfonyl
fluoride) were used for homogenization. The homogenate
was centrifuged at 12,000 rpm for 30 min and the super-
natants were collected. The protein concentration was
determined using a BCA method (Pierce, Rockford, IL).
The supernatant was mixed with a 29 loading buffer and
boiled for 5 min prior to SDS-PAGE (100 ug per lane).
Separated proteins were transferred onto a NC membrane.
After blocking the non-specific binding sites, samples were
incubated with a monoclonal anti-P-MLC20 antibody
(1:1,000 dilution, LifeSpan Biosciences) and a monoclonal
anti-MLCK antibody (1:500 dilution, LifeSpan Biosci-
ences) at 4 C overnight, followed by incubation with a
HRP-labeled secondary antibody. Protein bands were
visualized with an ECL reagent. P-MLC20 and MLCK
results were normalized against GAPDH.
Statistical analysis
All data were processed by the SAS V8.0 software and are
expressed as mean ± SD ðv  sÞ. Based on the data dis-
tribution and variance homogeneity test, t test or Wilcoxon
two-sample test was used to compare the data from the two
groups. A P value \0.05 was considered statistically
significant.
Results
The pathological changes in the common bile duct
of pediatric patients with PBM accompanied by BDD
HE staining revealed infiltration of the dilated common bile
duct with a large number of lymphocytes and mononuclear
cells. No atypical hyperplasia was found in the PBM
patients. In the PBM patients, the cystic wall of the com-
mon bile duct was composed of dense fibrous tissue,
scattered elastic fibers and smooth muscle fibers. The
epithelial lining of the cyst was damaged or even absent,
with different amount of chronic inflammatory cell infil-
tration. Intestinal metaplasia was observed in some cases.
The dilation common bile duct was cystic in 17 cases, spindle-
shaped in two cases and cylindrical in the two remaining cases.
The diameter of the common bile duct ranged from 1.2 to
6 cm, with a median diameter of 3 cm. The biliary starch
enzyme concentration was 2,558–1,48,854 U/L (average
47,373 U/L).
Immunohistochemistry
P-MLC20 was expressed mainly in the cytoplasm, with some
positive nucleus (Figs. 1, 2). In the PBM group, the MOD,
MLI and MQS of P-MLC20 were 115.6856 ± 58.1634,
21.7125 % ± 9.6555 and 21.3531 ± 6.5255, respectively.
In the control group, the MOD, MLI and MQS of
P-MLC20 were 96.5581 ± 9.7860, 11.1813 % ± 3.6208
and 10.7819 ± 3.5323, respectively. There was no signifi-
cant difference in MOD between the two groups (P [ 0.05),
whereas there was a significant difference of MLI and MQS
between the two groups (P \ 0.05) (Table 1).
P-MLC20 expression by Western blot
The relative expression of P-MLC20 was significantly
higher in the PBM group (0.6791 ± 0.3121) than in the
control group (0.3433 ± 0.2943; P \ 0.05) (Table 2,
Fig. 3).
Fig. 1 Representative immunohistochemical staining (9400) of
P-MLC20 in a 5-year-old patient
Pediatr Surg Int (2013) 29:293–298 295
123
MLCK expression by Western blot
The expression of MLCK was significantly higher in the
PBM group (1.8993 ± 1.1931) than in the control group
(1.0695 ± 0.8977) (P \ 0.05) (Table 3, Fig. 4).
Discussion
Poor bile flow in PBM induces cholestasis, and results
deconstruction of the bile duct wall, as well as changes in
the bile ducts inside and outside the liver. Cholestasis
induced by fibrosis of the common bile duct could increase
the pressure in the common bile duct and the dilation of the
common bile duct, and eventually common bile duct cysts.
Alonso-Lej et al. [4] reported that the common bile duct
wall is mainly composed of compact fibrous tissue, smooth
muscle and elastic fibers, and the bile duct wall in patients
with congenital bile duct dilation is thickened up to a
diameter of about 1 cm, suggesting that the changes in
morphology and function of the common bile duct is
accompanied by the changes in the tissue structure.
Myosin is a part of the skeleton structure of common
bile duct and pancreatic duct. The myosin–actin interaction
takes part in many biological processes, including muscle
contraction, cell motility, membrane transport of materials
and specific cell signal transduction [16]. Smooth muscle
contraction is induced by the sliding of thick against the
thin filaments. Similar to skeletal muscle, the myosin in
smooth muscle cell is composed of two heavy chains and
four light chains (two MLC20 and two LC17) [7]. The
intertwining of the two MHC forms the rod-shaped body
and globular head of thick filaments [6]. The globular head
has ATPase activity, and provides the energy for the rel-
ative sliding of thick and thin filaments by ATP hydrolysis.
Fig. 2 Representative immunohistochemical staining (9400) of
P-MLC20 in a control subject
Table 1 Image analysis of P-MLC20 expression in common bile









MOD 115.6856 ± 58.1634 96.5581 ± 9.7859 -0.7726 0.4456
MLI (%) 21.7125 ± 9.6554 11.1813 ± 3.6208 3.5239 0.0004
MQS 21.3531 ± 6.5255 10.7819 ± 3.5323 4.3154 0.0002
Wilcoxon two-sample test statistically significant (P \ 0.05)
Table 2 Analysis of P-MLC20 expression by Western blot in pan-
creaticobiliary maljunction accompanied by bile duct dilatation in
children versus control
Groups Cases v  s Z P
PBM ? BDD 12 0.6791 ± 0.3121 -2.3097 0.0209
Control 9 0.3433 ± 0.2943
Wilcoxon two-sample test
Fig. 3 Representative Western blot of P-MLC20 in the PBM group
(4, 5, 6) versus the control (1, 2, 3)
Table 3 Analysis of MLCK expression by Western blot in pancre-
aticobiliary maljunction accompanied by bile duct dilatation in chil-
dren versus control
Groups Cases v  s Z P
PBM ? BDD 12 1.8993 ± 1.1931 -2.2386 0.0252
Control 9 1.0695 ± 0.8977
Wilcoxon two-sample test
Fig. 4 Representative Western blot of MLCK in the PBM group (4,
5, 6) versus the control group (1, 2, 3)
296 Pediatr Surg Int (2013) 29:293–298
123
The above complex is dependent on myosin-Ca2?-ATPase.
The myosin light chain is subjected to regulation via
phosphorylation [17]. The myosin light chain is composed
of two regulatory light chains and basic light chains. The
phosphorylation of MLC20 is the main pathway that pro-
motes smooth muscle contraction [8].
The phosphorylation of MLC20 depends on the relative
activity of MLCK and MLCP. The regulatory pathways of
MLCP/MLCK include a calcium-dependent pathway and a
calcium-independent pathway [7]. It is generally accepted
that MLCK is activated after Ca2? binding to calmodulin,
and MLCK is most readily phosphorylated at Serine 19 of
MLC20 [18]. The second most commonly phosphorylation
site is Serine 18. The phosphorylation activates the Ca2?-
ATPase, which hydrolyzes ATP providing energy for the
interaction of myosin and actin, leading to muscle con-
traction. The region at which MLCK exerts its action is
located at the central kinase region, and the phosphoryla-
tion of MLC20 and Ca2? are required for inducing muscle
contraction [19].
Our results indicated a significant difference of MLI and
MQS between the two groups (P \ 0.05), but not MOD.
Furukawa et al. [20] suggested that it is more reasonable to
take both the positively stained area and stained intensity
into account for image analysis to limit the influence of
inter-individual variability. In the current study, we used a
MQS method developed by Hussan H et al. [15]. The
results showed that the P-MLC20 expression was increased
in the common bile duct in patients with PBM accompa-
nied by BDD. Higher expression of P-MLC20 was con-
firmed by Western blot analysis. Pfitzer and Arner [9]
reported that the content of phosphorylated MLC20 closely
correlated to muscle contractile force. If there was a change
of 8 % in P-MLC20, the change of muscle contraction
could be as high as 80 %. We speculate that the contractile
force of the smooth muscle of the common bile duct in
PBM patients is enhanced, which in turn triggers or
aggravates bile reflux to pancreatic duct in PBM. Most of
PBM cases have chronic inflammation in bile duct wall
[13]. Wang et al. [12] reported that cytokine release in
response to chronic inflammation induces intestinal epi-
thelial barrier dysfunction via increased phosphorylation of
MLC. High expression of P-MLC20 in common bile duct
in PBM accompanied by BDD could be secondary to the
chronic inflammation, and exacerbates the inflammation,
thus forming a vicious cycle. The likelihood that high
expression of P-MLC20 causes PBM, however, cannot be
ruled out.
The content of myosin regulatory light chains decreases
in patients with end-stage expansionary cardiomyopathy
[21]. The reduction of myosin regulatory light chains
could decrease the dissociation speed and affect muscle
contraction [22, 23]. MLCK is expressed in a variety of
non-muscle eukaryotic cells. MLCK is composed of four
regions: N-terminal actin-binding domain, central kinase
domain, calmodulin-binding domain and C-terminal myo-
sin-binding domain [24]. In smooth muscle contraction,
phosphorylation of MLC20 is regulated by MLCK path-
way, ZIP kinase pathway and integrin-related kinase
pathway [25, 26]. In our study, the MLCK expression was
significantly higher in PBM accompanied by BDD, sug-
gesting the contraction of the smooth muscle of the com-
mon bile duct is dependent on the phosphorylation of
MLC20 regulated by MLCK pathway. With enhanced
expression of phosphorylated MLC20, the contractile force
of the smooth muscle of the common bile duct is enhanced.
Using cultured gastric antral cells and smooth muscle cells
of the proximal small intestine, Huang et al. [27] evaluated
the role of G protein-dependent signaling pathway in reg-
ulating the initiation and maintenance of smooth muscle
contraction and phosphorylation of MLC20. The results
indicated that motilin initiates a transient Gaq-mediated
signaling cascade involving IP3-dependent Ca
2? release
and MLCK-dependent phosphorylation of MLC20. Motilin
acts on Gaq and Ga13-mediated signaling cascade
involving Rho kinase and PKC-dependent pathway, and
results in persistent phosphorylation of MLC20 and smooth
muscle contraction.
Improving the bile flow from the bile duct at resting
state is of vital importance for reducing the damages of the
bile duct, liver and pancreas. P-MLC20 expression was
enhanced in PBM accompanied by BDD patients. How-
ever, changes in the expression of MLC basic light chains
remains unclear.
In summary, we found that, with the occurrence of bil-
iary pancreatic reflux in pediatric patients with PBM
accompanied by BDD, the morphology of the common bile
duct was altered. P-MLC20 expression was increased, and
possibly contributed to increased contractile force of the
smooth muscle of the common bile duct by phosphorylat-
ing MLC20 via the MLCK pathway.
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